BM&FBOVESPA Receives Regulatory Approval For Ibovespa Equity Index Futures Accessible By U.S. Participants Through CME Group's Electronic Trading Network

BM&FBOVESPA, the largest exchange in Latin America, and CME Group, the world's largest and most diverse derivatives marketplace, have announced that BM&FBOVESPA has received regulatory approval enabling market participants trading from a U.S.- based account to trade futures and options for the world renowned Ibovespa stock index. Participants can access the Ibovespa contract through CME Globex(®), CME Group's electronic trading network, beginning immediately.

The listing is part of the order routing agreement that began last September that enables customers in Brazil to access CME Group products via the GTS electronic trading platform and CME Group customers to access BM&FBOVESPA products via CME Globex. To date, more than 4.5 million contracts have traded as a result of the partnership. Yesterday a record 97,000 contracts traded. Average daily volume in August has been 70,000 contracts.

The two exchanges are also jointly developing products for customers. As part of the arrangement between the two exchanges, CME Group owns a 5 percent equity stake in BM&FBOVESPA and BM&FBOVESPA owns a 1.7 percent of CME Group.